Takeda India Strengthens Patient Offering via Availability of Vedolizumab
Posted inHealthcare Highlight News

Takeda India Strengthens Patient Offering via Availability of Vedolizumab

Introduces innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn's Disease. Takeda India, part of the Takeda Pharmaceutical Company Ltd., a global values-based R&D-driven biopharmaceutical leader, today announced the expansion of its highly innovative portfolio for patients in the country with the launch of Kynteles® (generic name: Vedolizumab)…
India Now Has the World’s Second Largest Population with Inflammatory Bowel Disease (IBD)
Posted inHealthcare Highlight News

India Now Has the World’s Second Largest Population with Inflammatory Bowel Disease (IBD)

On May 19, the World IBD Day, leading Indian gastroenterologists come together for IBD Awareness Campaign #ManageYourIBD to complement the global movement around #MakeIBDWork. Wellness 365, a community representing leading Indian medical professionals and practitioners, today announced that India today has an estimated 1.5 million patients affected by the Inflammatory…